Tuberculosis Therapy
Study results from Duke University, Division of Infectious Diseases broaden understanding of tuberculosis therapy
Published in Drug Week, October 3rd, 2008
Scientists discuss in 'The value of end-of-treatment chest radiograph in predicting pulmonary tuberculosis relapse' new findings in tuberculosis. According to a study from the United States, "Patients with cavitary pulmonary tuberculosis (TB) on baseline chest radiograph (CXR) who remain culture-positive after 8 weeks of treatment are at high risk of relapse. The role of end-of-treatment (EOT) CXR in predicting relapse is unclear."
"To determine whether EOT CXR independently predicts TB relapse. We conducted a secondary analysis of a randomized trial of intermittent treatment using rifapentine in the continuation phase of TB treatment among 1004 human immunodeficiency...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
Source: Drug Week (2008-10-03)
More Articles from Drug Week
- American Association for Cancer Research
New tool to speed cancer therapy approval available - American Association for Cancer Research
Vaccine against HER2-positive breast cancer offers complete protection in lab - American College of Physicians
Massage therapy may have immediate positive effect on pain and mood for advanced cancer patients - CV Technologies Inc.
Colds and flu cut by one-third in study of Canada's top cold fighter in vaccinated seniors - European Society for Medical Oncology
Chemotherapy, radiotherapy and cetuximab in head and neck cancer - European Society for Medical Oncology
Pazopanib shrinks lung cancers before surgery - More from this issue of Drug Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
